Medtronic PLC
MDT98.660USD
-1.210-1.21%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
126.48BCap. mercado
26.55P/E TTM
Más Datos de Medtronic PLC Compañía
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Información de Medtronic PLC
Símbolo de cotizaciónMDT
Nombre de la empresaMedtronic PLC
Fecha de salida a bolsaNov 21, 1977
Director ejecutivoMartha (Geoffrey S)
Número de empleados95000
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 21
DirecciónBuilding Two Parkmore Business Park West
CiudadDUBLIN
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIreland
Código postalH91 4K49
Teléfono1135314381700
Sitio Webhttps://www.medtronic.com/
Símbolo de cotizaciónMDT
Fecha de salida a bolsaNov 21, 1977
Director ejecutivoMartha (Geoffrey S)
Ejecutivos de Medtronic PLC
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+0.89%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+0.41%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+0.89%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-81.26%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
Otro
2.41B
28.11%
Por regiónUSD
Nombre
Ganancia
Proporción
Rest of World
4.32B
50.37%
United States
4.22B
49.24%
Ireland
33.00M
0.38%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
Otro
2.41B
28.11%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
Otro
74.57%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
Otro
74.57%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
46.90%
Investment Advisor/Hedge Fund
29.42%
Research Firm
4.18%
Pension Fund
2.40%
Bank and Trust
2.17%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Insurance Company
0.38%
Individual Investor
0.28%
Otro
11.49%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
126.32M
9.85%
+1.88M
+1.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
67.84M
5.29%
-1.09M
-1.58%
Jun 30, 2025
State Street Investment Management (US)
59.83M
4.66%
-210.22K
-0.35%
Jun 30, 2025
JP Morgan Asset Management
26.31M
2.05%
-1.69M
-6.03%
Jun 30, 2025
Capital Research Global Investors
36.36M
2.83%
-5.21M
-12.53%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.23M
2.2%
+310.68K
+1.11%
Jun 30, 2025
MFS Investment Management
19.36M
1.51%
-1.24M
-6.04%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
13.77M
1.07%
-170.61K
-1.22%
Jun 30, 2025
BlackRock Financial Management, Inc.
15.63M
1.22%
+1.48M
+10.48%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
Ver más
Absolute Select Value ETF
Proporción4.89%
iShares U.S. Medical Devices ETF
Proporción4.4%
iShares Health Innovation Active ETF
Proporción4.26%
Cullen Enhanced Equity Income ETF
Proporción4.24%
USCF Dividend Income Fund
Proporción3.59%
JPMorgan Healthcare Leaders ETF
Proporción3.22%
Madison Dividend Value ETF
Proporción3.08%
Tema Heart & Health ETF
Proporción2.98%
Global X Aging Population ETF
Proporción2.98%
WisdomTree US AI Enhanced Value Fund
Proporción2.86%
Dividendos
Un total de
17.37B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Medtronic PLC?
Los cinco principales accionistas de Medtronic PLC son:
The Vanguard Group, Inc. posee 126.32M acciones, lo que representa el 9.85% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 67.84M acciones, lo que representa el 5.29% del total de acciones.
State Street Investment Management (US) posee 59.83M acciones, lo que representa el 4.66% del total de acciones.
JP Morgan Asset Management posee 26.31M acciones, lo que representa el 2.05% del total de acciones.
Capital Research Global Investors posee 36.36M acciones, lo que representa el 2.83% del total de acciones.
The Vanguard Group, Inc. posee 126.32M acciones, lo que representa el 9.85% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 67.84M acciones, lo que representa el 5.29% del total de acciones.
State Street Investment Management (US) posee 59.83M acciones, lo que representa el 4.66% del total de acciones.
JP Morgan Asset Management posee 26.31M acciones, lo que representa el 2.05% del total de acciones.
Capital Research Global Investors posee 36.36M acciones, lo que representa el 2.83% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Medtronic PLC?
Los tres principales tipos de accionista de Medtronic PLC son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
¿Cuántas instituciones poseen acciones de Medtronic PLC (MDT)?
A fecha de 2025Q3, 3723 instituciones poseen acciones de Medtronic PLC, con un valor de mercado combinado de aproximadamente 1.13B, lo que representa el 88.20% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 1.08%.
¿Cuál es la mayor fuente de ganancias de Medtronic PLC?
El FY2026Q1, el segmento empresarial Cardiac Rhythm & Heart Failure generó la ganancia más alta para Medtronic PLC, ascendiendo a 1.71B y representando el 19.96% de la ganancia total.
